These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 22591362)
1. Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine. Conant K; Lim ST; Randall B; Maguire-Zeiss KA Curr HIV Res; 2012 Jul; 10(5):384-91. PubMed ID: 22591362 [TBL] [Abstract][Full Text] [Related]
2. HIV and substance abuse: a commentary. Shurtleff D; Lawrence D Curr HIV Res; 2012 Jul; 10(5):366-8. PubMed ID: 22591360 [No Abstract] [Full Text] [Related]
4. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era. Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation. Conant K; Wang Y; Szklarczyk A; Dudak A; Mattson MP; Lim ST Neuroscience; 2010 Mar; 166(2):508-21. PubMed ID: 20045450 [TBL] [Abstract][Full Text] [Related]
6. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs. Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747 [TBL] [Abstract][Full Text] [Related]
7. Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents. Mizoguchi H; Yamada K; Nabeshima T J Pharmacol Sci; 2008 Jan; 106(1):9-14. PubMed ID: 18198472 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Silverstein PS; Shah A; Weemhoff J; Kumar S; Singh DP; Kumar A Curr HIV Res; 2012 Jul; 10(5):369-83. PubMed ID: 22591361 [TBL] [Abstract][Full Text] [Related]
9. Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus. Benekareddy M; Mehrotra P; Kulkarni VA; Ramakrishnan P; Dias BG; Vaidya VA Synapse; 2008 Aug; 62(8):590-600. PubMed ID: 18509851 [TBL] [Abstract][Full Text] [Related]
10. MMP-9 Signaling Pathways That Engage Rho GTPases in Brain Plasticity. Figiel I; Kruk PK; Zaręba-Kozioł M; Rybak P; Bijata M; Wlodarczyk J; Dzwonek J Cells; 2021 Jan; 10(1):. PubMed ID: 33467671 [TBL] [Abstract][Full Text] [Related]
11. HIV and drug abuse mediate astrocyte senescence in a β-catenin-dependent manner leading to neuronal toxicity. Yu C; Narasipura SD; Richards MH; Hu XT; Yamamoto B; Al-Harthi L Aging Cell; 2017 Oct; 16(5):956-965. PubMed ID: 28612507 [TBL] [Abstract][Full Text] [Related]
12. Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system. Hoefer MM; Sanchez AB; Maung R; de Rozieres CM; Catalan IC; Dowling CC; Thaney VE; Piña-Crespo J; Zhang D; Roberts AJ; Kaul M Exp Neurol; 2015 Jan; 263():221-34. PubMed ID: 25246228 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages. Reynolds JL; Mahajan SD; Aalinkeel R; Nair B; Sykes DE; Schwartz SA Immunol Invest; 2011; 40(5):481-97. PubMed ID: 21425912 [TBL] [Abstract][Full Text] [Related]
14. Mephedrone Impact on Matrix Metalloproteinases Activity - Do they Influence the Memory Processes? Boguszewska-Czubara A; Kurzepa J; Biała G; Kaszubska K; Grot K; Tarkowski P; Kowalczyk J; Silvestro S; Faggio C; Budzyńska B Curr Mol Pharmacol; 2019; 12(2):115-121. PubMed ID: 30648530 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine. Nair MP; Samikkannu T Curr HIV Res; 2012 Jul; 10(5):429-34. PubMed ID: 22591367 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system. Verslegers M; Lemmens K; Van Hove I; Moons L Prog Neurobiol; 2013 Jun; 105():60-78. PubMed ID: 23567503 [TBL] [Abstract][Full Text] [Related]
17. In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection. Gramegna P; Latronico T; Branà MT; Di Bari G; Mengoni F; Belvisi V; Mascellino MT; Lichtner M; Vullo V; Mastroianni CM; Liuzzi GM PLoS One; 2011; 6(12):e28499. PubMed ID: 22174822 [TBL] [Abstract][Full Text] [Related]
18. Melatonin improves functional outcome via inhibition of matrix metalloproteinases-9 after photothrombotic spinal cord injury in rats. Piao MS; Lee JK; Jang JW; Hur H; Lee SS; Xiao L; Kim HS Acta Neurochir (Wien); 2014 Nov; 156(11):2173-82. PubMed ID: 24879621 [TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. Conant K; St Hillaire C; Anderson C; Galey D; Wang J; Nath A J Neurovirol; 2004 Feb; 10(1):21-8. PubMed ID: 14982725 [TBL] [Abstract][Full Text] [Related]
20. Berberine's effect on periodontal tissue degradation by matrix metalloproteinases: an in vitro and in vivo experiment. Tu HP; Fu MM; Kuo PJ; Chin YT; Chiang CY; Chung CL; Fu E Phytomedicine; 2013 Oct; 20(13):1203-10. PubMed ID: 23867651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]